PROMINENT

IHE is proud to be part of the PROMINENT consortium, working together to create a digital platform for precision medicine with the aim of improving the lives of patients with neurodegenerative diseases and co-morbidities. PROMINENT is funded through the Innovative Health Initiative (IHI) and brings together experts in neurodegenerative diseases and clinical neuroscience, artificial intelligence (AI), health economics, and patient advocacy.

IHE leads the part of the project that aims at designing, implementing, and evaluating a process to gather real-world evidence from the digital platform for the evaluation of new technologies, with an initial focus on disease-modifying therapies for Alzheimer’s disease.